🚀 VC round data is live in beta, check it out!

Sphere Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sphere and similar public comparables like iFLYHealth, U.S. Physical Therapy, Vitec Software, B-Soft Co. and more.

Sphere Overview

About Sphere

Sphere Corp Formerly Life Semantics Corp is engaged in the development and supply of innovative healthcare solutions such as providing a technology platform for digital transformation in the healthcare field and non-face-to-face medical and digital treatment devices.


Founded

2012

HQ

South Korea

Employees

N/A

Financials (FY)

Revenue: $65M
EBITDA: $6M

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sphere Financials

Sphere reported last fiscal year revenue of $65M and EBITDA of $6M.

In the same fiscal year, Sphere generated $11M in gross profit, $6M in EBITDA, and $115K in net income.


Sphere P&L

In the most recent fiscal year, Sphere reported revenue of $65M and EBITDA of $6M.

Sphere expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Sphere forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$65MXXXXXXXXX
Gross ProfitXXX$11MXXXXXXXXX
Gross MarginXXX18%XXXXXXXXX
EBITDAXXX$6MXXXXXXXXX
EBITDA MarginXXX10%XXXXXXXXX
EBIT MarginXXX9%XXXXXXXXX
Net ProfitXXX$115KXXXXXXXXX
Net MarginXXX0%XXXXXXXXX
Net Debt$6MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Sphere Stock Performance

Sphere has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


Sphere's stock price is $31.16.

See Sphere trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-0.5%XXXXXXXXX$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sphere Valuation Multiples

Sphere trades at 17.1x EV/Revenue multiple, and 179.0x EV/EBITDA.

See valuation multiples for Sphere and 15K+ public comps

Sphere Financial Valuation Multiples

As of April 19, 2026, Sphere has market cap of $1B and EV of $1B.

Equity research analysts estimate Sphere's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Sphere has a P/E ratio of 9583.5x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$1BXXX$1BXXXXXXXXX
EV/RevenueXXX17.1xXXXXXXXXX
EV/EBITDAXXX179.0xXXXXXXXXX
EV/EBITXXX180.9xXXXXXXXXX
EV/Gross ProfitXXX97.2xXXXXXXXXX
P/EXXX9583.5xXXXXXXXXX
EV/FCFXXX(111.3x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sphere Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sphere Margins & Growth Rates

Sphere's revenue in the last fiscal year grew by 3639%.

See operational valuation multiples for Sphere and other 15K+ public comps

Sphere Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX3639%XXXXXXXXX
EBITDA MarginXXX10%XXXXXXXXX
EBITDA GrowthXXX(176%)XXXXXXXXX
S&M Expenses to RevenueXXX5%XXXXXXXXX
G&A Expenses to RevenueXXX0%XXXXXXXXX
R&D Expenses to RevenueXXX0%XXXXXXXXX
Opex to RevenueXXX8%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sphere Public Comps

See public comps and valuation multiples for other Healthcare Software and Digital Therapeutics comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
SphereXXXXXXXXXXXXXXXXXX
iFLYHealthXXXXXXXXXXXXXXXXXX
U.S. Physical TherapyXXXXXXXXXXXXXXXXXX
Vitec SoftwareXXXXXXXXXXXXXXXXXX
B-Soft Co.XXXXXXXXXXXXXXXXXX
IndegeneXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Sphere M&A Activity

Sphere acquired XXX companies to date.

Last acquisition by Sphere was on XXXXXXXX, XXXXX. Sphere acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Sphere

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Sphere Investment Activity

Sphere invested in XXX companies to date.

Sphere made its latest investment on XXXXXXXX, XXXXX. Sphere invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Sphere

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sphere

When was Sphere founded?Sphere was founded in 2012.
Where is Sphere headquartered?Sphere is headquartered in South Korea.
Is Sphere publicly listed?Yes, Sphere is a public company listed on Korea Exchange.
What is the stock symbol of Sphere?Sphere trades under 347700 ticker.
When did Sphere go public?Sphere went public in 2021.
Who are competitors of Sphere?Sphere main competitors are iFLYHealth, U.S. Physical Therapy, Vitec Software, B-Soft Co..
What is the current market cap of Sphere?Sphere's current market cap is $1B.
What is the current revenue of Sphere?Sphere's last fiscal year revenue is $65M.
What is the current EV/Revenue multiple of Sphere?Current revenue multiple of Sphere is 17.1x.
Is Sphere profitable?No, Sphere is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial